148 related articles for article (PubMed ID: 32221362)
1. Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury.
Udomsinprasert W; Chanhom N; Suvichapanich S; Wattanapokayakit S; Mahasirimongkol S; Chantratita W; Jittikoon J
Sci Rep; 2020 Mar; 10(1):5628. PubMed ID: 32221362
[TBL] [Abstract][Full Text] [Related]
2. Global DNA hypomethylation of Alu and LINE-1 transposable elements as an epigenetic biomarker of anti-tuberculosis drug-induced liver injury.
Udomsinprasert W; Sakuntasri W; Jittikoon J; Chaikledkaew U; Honsawek S; Chantratita W; Wattanapokayakit S; Mahasirimongkol S
Emerg Microbes Infect; 2021 Dec; 10(1):1862-1872. PubMed ID: 34467830
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial DNA content as a diagnostic marker for antituberculosis drug-induced liver injury.
Udomsinprasert W; Jittikoon J; Chaikledkaew U; Saengsiwaritt W; Chanhom N; Suvichapanich S; Wattanapokayakit S; Mahasirimongkol S; Chantratita W
Int J Infect Dis; 2022 Sep; 122():1034-1040. PubMed ID: 35931370
[TBL] [Abstract][Full Text] [Related]
4. The susceptibility of anti-tuberculosis drug-induced liver injury and chronic hepatitis C infection: A systematic review and meta-analysis.
Chang TE; Huang YS; Chang CH; Perng CL; Huang YH; Hou MC
J Chin Med Assoc; 2018 Feb; 81(2):111-118. PubMed ID: 29198550
[TBL] [Abstract][Full Text] [Related]
5. The relationship between relative telomere length and anti-tuberculosis drug-induced hepatitis : A case-control study.
Liu W; Wang N; Zhu J; Zhang M; Lu L; Pan H; He X; Yi H; Tang S
Therapie; 2023; 78(3):259-266. PubMed ID: 35710461
[TBL] [Abstract][Full Text] [Related]
6. Association of POR and PPARα polymorphisms with risk of anti-tuberculosis drug-induced liver injury in Western Chinese Han population.
Zhang C; Jiao L; Bai H; Zhao Z; Hu X; Wang M; Wu T; Peng W; Liu T; Song J; Zhou J; Li M; Lyv M; Zhang J; Chen H; Chen J; Ying B
Infect Genet Evol; 2020 Apr; 79():104147. PubMed ID: 31857256
[TBL] [Abstract][Full Text] [Related]
7. Telomere Length in Peripheral Blood Leukocytes Is Associated with Severity of Biliary Atresia.
Udomsinprasert W; Poovorawan Y; Chongsrisawat V; Vejchapipat P; Zhan D; Honsawek S
PLoS One; 2015; 10(7):e0134689. PubMed ID: 26230851
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, risk factors, management, and treatment outcomes of first-line antituberculous drug-induced liver injury: a prospective cohort study.
Sun Q; Zhang Q; Gu J; Sun WW; Wang P; Bai C; Xiao HP; Sha W
Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):908-17. PubMed ID: 26935778
[TBL] [Abstract][Full Text] [Related]
9. Relative telomere length and oxidative stress in musculoskeletal tumors.
Tanpaisankit M; Hongsaprabhas C; Chareonlap C; Honsawek S
Mol Biol Rep; 2019 Aug; 46(4):4009-4016. PubMed ID: 31069615
[TBL] [Abstract][Full Text] [Related]
10. Telomere length in peripheral leukocytes is associated with immune cell tumor infiltration and prognosis in colorectal cancer patients.
Svenson U; Öberg Å; Stenling R; Palmqvist R; Roos G
Tumour Biol; 2016 Aug; 37(8):10877-82. PubMed ID: 26883253
[TBL] [Abstract][Full Text] [Related]
11. The association between cytochrome P450 polymorphisms and anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis.
Liu X; Ren S; Zhang J; Xu D; Jiang F; Jiang P; Feng J; Deng F
Ann Palliat Med; 2021 Jun; 10(6):6518-6534. PubMed ID: 34154362
[TBL] [Abstract][Full Text] [Related]
12. Genetic Polymorphisms in Antioxidant Enzymes Modulate the Susceptibility of Idiosyncratic Antituberculous Drug-Induced Liver Injury and Treatment Outcomes in Patients with Tuberculosis.
Sun Q; Sha W; Liu HP; Wang P; Liu ZB; Sun WW; Xiao HP
Pharmacotherapy; 2020 Jan; 40(1):4-16. PubMed ID: 31742742
[TBL] [Abstract][Full Text] [Related]
13. Relationship between xanthine oxidase gene polymorphisms and anti-tuberculosis drug-induced liver injury in a Chinese population.
Ai X; Huang H; Miao Z; Zhou T; Wu H; Lai Y
Infect Genet Evol; 2021 Sep; 93():104991. PubMed ID: 34229066
[TBL] [Abstract][Full Text] [Related]
14. Association between leukocyte telomere length and glioma risk: a case-control study.
Wang S; Chen Y; Qu F; He S; Huang X; Jiang H; Jin T; Wan S; Xing J
Neuro Oncol; 2014 Apr; 16(4):505-12. PubMed ID: 24366909
[TBL] [Abstract][Full Text] [Related]
15. NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis.
Suvichapanich S; Fukunaga K; Zahroh H; Mushiroda T; Mahasirimongkol S; Toyo-Oka L; Chaikledkaew U; Jittikoon J; Yuliwulandari R; Yanai H; Wattanapokayakit S; Tokunaga K
Pharmacogenet Genomics; 2018 Jul; 28(7):167-176. PubMed ID: 29781872
[TBL] [Abstract][Full Text] [Related]
16. Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Bao D; Ba Y; Zhou F; Zhao J; Yang Q; Ge N; Guo X; Wu Z; Zhang H; Yang H; Wan S; Xing J
Cancer Chemother Pharmacol; 2016 Oct; 78(4):791-9. PubMed ID: 27558242
[TBL] [Abstract][Full Text] [Related]
17. The genetic variants in calcium signaling related genes influence anti-tuberculosis drug induced liver injury: A prospective study.
Lyu M; Zhou J; Chen H; Bai H; Song J; Liu T; Cheng Y; Ying B
Medicine (Baltimore); 2019 Nov; 98(44):e17821. PubMed ID: 31689868
[TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis B infection and risk of antituberculosis drug-induced liver injury: Systematic review and meta-analysis.
Wang NT; Huang YS; Lin MH; Huang B; Perng CL; Lin HC
J Chin Med Assoc; 2016 Jul; 79(7):368-74. PubMed ID: 27032895
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury.
Zhang J; Zhao Z; Bai H; Wang M; Jiao L; Peng W; Wu T; Liu T; Chen H; Song X; Wu L; Hu X; Wu Q; Zhou J; Song J; Lyv M; Ying B
PLoS One; 2019; 14(9):e0222033. PubMed ID: 31490979
[TBL] [Abstract][Full Text] [Related]
20. Short telomere length in peripheral blood leukocyte predicts poor prognosis and indicates an immunosuppressive phenotype in gastric cancer patients.
Qu F; Li R; He X; Li Q; Xie S; Gong L; Ji G; Lu J; Bao G
Mol Oncol; 2015 Mar; 9(3):727-39. PubMed ID: 25515040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
